TITLE

Could the Difference Between Normal and Malignant Stem Cells Eradicate Cancer?

AUTHOR(S)
Ivanovic, Zoran
PUB. DATE
October 2013
SOURCE
Scripta Medica;Oct2013, Vol. 44 Issue 2, p74
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The authors discuss the role of normal stem cells in the eradication of cancer. They consider cellular therapy as a real medical revolution prompted by stem cell research in the 21st century. They describe the commonality between normal and cancer stem cells based on the findings of stem cell research.
ACCESSION #
90578889

 

Related Articles

  • Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantation. Majhail, N S; Rizzo, J D; Hahn, T; Lee, S J; McCarthy, P L; Ammi, M; Denzen, E; Drexler, R; Flesch, S; James, H; Omondi, N; Pedersen, T L; Murphy, E; Pederson, K // Bone Marrow Transplantation;Jun2013, Vol. 48 Issue 6, p865 

    Patient/caregiver out-of pocket costs associated with hematopoietic cell transplantation (HCT) are not well known. We conducted a pilot study to evaluate patient/caregiver out-of-pocket costs in the first 3 months after allogeneic HCT. Thirty patients were enrolled at three sites. Before HCT,...

  • Blazing a new TRAIL in hematopoietic cell transplantation. Chao, Nelson // Journal of Clinical Investigation;Jul2013, Vol. 123 Issue 7, p2362 

    There is a ying/yang to most biological therapies, and the balance of efficacy versus toxicity is delicate and sometimes difficult to achieve in favor of the patients. When the therapeutic window is wide, these therapies can be used in the majority of patients, but when the therapeutic window is...

  • Ä°ndüklenmiÅŸ pluripotent kök hücreler ve hücre tedavisi. İskender, Banu; Canatan, Halit // Journal of Clinical & Experimental Investigations / Klinik ve De;Dec2013, Vol. 4 Issue 4, p550 

    Human embryonic stem cells are derived from the inner cell mass of a blastocyst-stage embryo. They hold a huge promise for cell therapy with their self-renewing ability and pluripotency, which is known as the potential to differentiate into all cell types originating from three embryonic germ...

  • Safer Way to Produce Stem Cell Alternative Demonstrated. ANDRUSKO, DAVE // National Right to Life News;Mar2009, Vol. 36 Issue 3, p12 

    The article discusses research being done on a new way to more safely reprogram adult stem cells which can provide a virtually limitless supply of embryonic-like stem cells called induced pluripotent stem (iPS) cells. It references studies by Andras Nagy and Keisuke Kaji, published in "Nature."...

  • Cell therapy in the heart. Abdelli, Latifa S.; Merino, Hilda; Rocher, Crystal M.; Singla, Dinender K. // Canadian Journal of Physiology & Pharmacology;Mar2012, Vol. 90 Issue 3, p307 

    Cell therapy is emerging as a new strategy to circumvent the adverse effects of heart disease. Many experimental and clinical studies investigating the transplantation of cells into the injured myocardium have yielded promising results. Moreover, data from these reports show that transplanted...

  • Memory in disguise. Sallusto, Federica; Lanzavecchia, Antonio // Nature Medicine;Oct2011, Vol. 17 Issue 10, p1182 

    In this article, the authors discuss the study of L. Gattinoni and colleagues on memory stem cells (TSCM). The authors say that the study, which was published in the October 2011 issue of the journal "Nature Medicine," reports the identification of such cells in humans, describing them...

  • Tracking the engraftment and regenerative capabilities of transplanted lung stem cells using fluorescent nanodiamonds. Wu, Tsai-Jung; Tzeng, Yan-Kai; Chang, Wei-Wei; Cheng, Chi-An; Kuo, Yung; Chien, Chin-Hsiang; Chang, Huan-Cheng; Yu, John // Nature Nanotechnology;Sep2013, Vol. 8 Issue 9, p682 

    Lung stem/progenitor cells are potentially useful for regenerative therapy, for example in repairing damaged or lost lung tissue in patients. Several optical imaging methods and probes have been used to track how stem cells incorporate and regenerate themselves in vivo over time. However, these...

  • Enabling stem cell therapies through synthetic stem cell-niche engineering. Peerani, Raheem; Zandstra, Peter W. // Journal of Clinical Investigation;Jan2010, Vol. 120 Issue 1, p60 

    Enabling stem cell-targeted therapies requires an understanding of how to create local microenvironments (niches) that stimulate endogenous stem cells or serve as a platform to receive and guide the integration of transplanted stem cells and their derivatives. In vivo, the stem cell niche is a...

  • Inhibition of PTEN Tumor Suppressor Promotes the Generation of Induced Pluripotent Stem Cells. Liao, Jiyuan; Marumoto, Tomotoshi; Yamaguchi, Saori; Okano, Shinji; Takeda, Naoki; Sakamoto, Chika; Kawano, Hirotaka; Nii, Takenobu; Miyamato, Shohei; Nagai, Yoko; Okada, Michiyo; Inoue, Hiroyuki; Kawahara, Kohichi; Suzuki, Akira; Miura, Yoshie; Tani, Kenzaburo // Molecular Therapy;Jun2013, Vol. 21 Issue 6, p1242 

    Induced pluripotent stem cells (iPSCs) can be generated from patients with specific diseases by the transduction of reprogramming factors and can be useful as a cell source for cell transplantation therapy for various diseases with impaired organs. However, the low efficiency of iPSC derived...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics